Ipsen is a FRENCH owned and operated company who has lost over 550$ million in US launch efforts. This will continue as they enter as a very very very small player inside Oncology
Launch meeting completed. Unsuccessful sales team has no comp plan. Competition is Novartis. Ipsen reputation extremely poor in US markets